Drug & intervention
droperidol
RxCUI 3648
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Background context
Droperidol
Droperidol (Inapsine, Droleptan, Dridol, Xomolix, Innovar [combination with fentanyl]) is an antidopaminergic drug used as an antiemetic (that is, to prevent or treat nausea) and as an antipsychotic. Droperidol is also often used as a rapid sedative in intensive-care treatment, and where "agitation aggression or violent behavior" are present.
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
1 shownConditions being studied
Research locations
Ann ArborMichigan, United States1AtlantaGeorgia, United States1AustinTexas, United States1DenverColorado, United States1EugeneOregon, United States1Fort WorthTexas, United States1Grand RapidsMichigan, United States1Kansas CityMissouri, United States1MiamiFlorida, United States1NashvilleTennessee, United States1New YorkNew York, United States1Oklahoma CityOklahoma, United States1
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.